The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes of patients with HER2-positive invasive lobular carcinoma in the ALTTO trial (BIG 2-06/NCCTG N063D [Alliance]).
 
Guilherme Nader Marta
Travel, Accommodations, Expenses - AstraZeneca
 
Lieveke Ameye
No Relationships to Disclose
 
Giuseppe Viale
Honoraria - Daiichi Sankyo Europe GmbH; Gilead Sciences
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; DAKO; Menarini; MSD Oncology; Novartis; Roche/Genentech
Research Funding - AstraZeneca (Inst); Cepheid (Inst); DAKO (Inst); Roche (Inst); Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH
 
Diogo Martins-Branco
Employment - ESMO
Research Funding - F. Hoffmann LaRoche (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
(OPTIONAL) Uncompensated Relationships - American Society of Clinical Oncology; Associação de Investigação e Cuidados de Suporte em Oncologia - Portuguese MASCC affiliate; Associação Portuguesa de Cuidados Paliativos; Multinational Association of Supportive Care in Cancer; Sociedade Portuguesa de Oncologia
 
Marianne Paesmans
No Relationships to Disclose
 
Philippe Aftimos
Honoraria - Gilead Sciences; Roche; Synthon
Consulting or Advisory Role - Amcure; Amgen; Boehringer Ingelheim; Deloitte; G1 Therapeutics; Gilead Sciences; Incyte; Lilly; Macrogenics; Menarini; Novartis; Novartis; Radius Health; Roche; Servier
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD Oncology; Pfizer; Roche Belgium
 
Christine Desmedt
Consulting or Advisory Role - AstraZeneca (Inst); Lilly (Inst)
Expert Testimony - Lilly (Inst)
 
Anup Choudhury
Employment - Novartis
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
 
Antonio Wolff
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.
 
Ian Krop
Employment - PureTech (I)
Leadership - PureTech (I)
Stock and Other Ownership Interests - PureTech (I)
Honoraria - AstraZeneca; Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech/Roche; Merck; Merck KGaA; Novartis; Seagen
Research Funding - Genentech (Inst); Macrogenics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - anti-murine CD19 monoclonal antibody licensed to PharMingen
 
Martine Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Frame Therapeutics; Gilead Sciences; Lilly; Menarini; MSD; NBE Therapeutics; Novartis; Pfizer; Roche/Genentech; Seagen; Seagen
Research Funding - AstraZeneca (Inst); Immunomedics/Gilead (Inst); Lilly (Inst); Menarini (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); Servier (Inst); Synthon (Inst)
Other Relationship - Oncolytics
 
Evandro de Azambuja
Honoraria - AstraZeneca; Gilead Sciences; Libbs (Inst); Lilly; MSD Oncology; Novartis/Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech; SeaGen; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca (Inst); Libbs; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline/Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences
(OPTIONAL) Uncompensated Relationships - Belgian Society of Medical Oncology (BSMO); ESMO